EUVIMEDEUVIMED entdecken
Crossref

The Enigma of Norse and Fires: Clinical Profile and Outcomes in a Tertiary Care Setting

M. L. N. Phanindher, T. Surya Prabha

International Journal of Epilepsy · 01.08.2026 · 12 (S 01 S 01) · S3-S35

DOI: 10.1055/s-0046-1825929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Epilepsy, erschienen am 01.08.2026. Verfasst von M. L. N. Phanindher und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

New-onset refractory status epilepticus (NORSE) is a severe form of status epilepticus occurring without preexisting epilepsy or identifiable acute structural, toxic, or metabolic cause within 72 hours. Febrile infection-related epilepsy syndrome (FIRES) is a subtype preceded by a febrile illness 2 weeks to 24 hours before onset. A substantial proportion of cases remain cryptogenic, posing major diagnostic and therapeutic challenges.

Objectives

To characterize the clinical profile and treatment outcomes of NORSE and FIRES, compare cryptogenic NORSE with FIRES, and identify correlations between treatment modalities, disease parameters, and functional outcomes.

Methods

A single-center prospective study was conducted at a tertiary care hospital. Twenty patients presenting with refractory (RSE) or super-refractory status epilepticus (SRSE) were enrolled after excluding acute structural, toxic, or metabolic causes. Patients were classified into known and unknown etiology groups. Demographics, seizure type, time to first antiseizure medication (ASM), electroencephalography, magnetic resonance imaging (MRI), cerebrospinal fluid autoimmune and paraneoplastic antibody panels, immunotherapy details, and functional outcomes (Glasgow Outcome Scale, GOS) at discharge were recorded and analyzed using chi-square tests and t -tests ( p 12 hours) strongly correlated with SRSE ( p = 0.001) and poor functional outcome ( p = 0.001). SE duration > 14 days was associated with significantly worse outcomes ( p = 0.008). Hippocampal and cortical atrophy on MRI significantly predicted medication-refractory seizures ( p = 0.018). Overall, 60% had poor functional outcomes (GOS < 4).

Conclusion

Early initiation of antiseizure therapy is the single most critical determinant of outcome in NORSE/FIRES. Unknown etiology, prolonged SE, and MRI-evident hippocampal atrophy are key predictors of poor prognosis. Standardized treatment protocols, robust autoimmune workup, and timely immunotherapy are essential to improve outcomes in this rare but devastating condition. Publication History Article published online: 15 July 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Private Limited A-13A, Graphix Tower 1, 6th floor, Sector 62, Noida 201309, Uttar Pradesh, India

Zitieren

APA

Phanindher, M. L. N., & Prabha, T. S. (2026). The Enigma of Norse and Fires: Clinical Profile and Outcomes in a Tertiary Care Setting. International Journal of Epilepsy, 12(S 01 S 01), S3-S35. https://doi.org/10.1055/s-0046-1825929

Vancouver

Phanindher MLN, Prabha TS. The Enigma of Norse and Fires: Clinical Profile and Outcomes in a Tertiary Care Setting. International Journal of Epilepsy. 2026;12(S 01 S 01):S3-S35. doi:10.1055/s-0046-1825929

BibTeX
@article{Phanindher2026,
  author = {Phanindher, M. L. N. and Prabha, T. Surya},
  title = {The Enigma of Norse and Fires: Clinical Profile and Outcomes in a Tertiary Care Setting},
  journal = {International Journal of Epilepsy},
  year = {2026},
  volume = {12},
  number = {S 01 S 01},
  pages = {S3--S35},
  doi = {10.1055/s-0046-1825929}
}
Kostenlos starten →